Prognostic Value of Reduced SMAD4 Expression in Patients With Metastatic Colorectal Cancer Under Oxaliplatin-Containing Chemotherapy: A Translational Study of the AIO Colorectal Study Group
Clinical Colorectal Cancer , Volume 10, pp 24-29; doi:10.3816/ccc.2011.n.003
The publisher has not yet granted permission to display this abstract.
Keywords: SMAD4 expression / Colorectal Study / Prognostic Value / oxaliplatin containing / study group / patients with metastatic
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Clinical Colorectal Cancer" .